Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine model

Conclusions Our data indicate that topical treatment with a formulation containing azithromycin is a promising approach to prevent Lyme borreliosis shortly after a tick bite. (Source: Journal of Antimicrobial Chemotherapy)

 

Objectives

Systemic antibiotic treatment of Lyme borreliosis is effective during the early stages of the infection, while chronic manifestations of the disease may remain refractory and difficult to treat. This study was carried out in order to evaluate the potential of topically applied azithromycin to eliminate the spirochaetal organisms in the skin of the freshly bitten host and thereby prevent Lyme borreliosis.

Methods

Laboratory mice were challenged with

Borrelia burgdorferi sensu stricto

Results

Concentrations of azithromycin in murine skin were >3800-fold higher than the published minimal inhibitory concentration for

B. burgdorferi

Conclusions

Our data indicate that topical treatment with a formulation containing azithromycin is a promising approach to prevent Lyme borreliosis shortly after a tick bite.

(Visited 25 times, 1 visits today)
Subscribe to Jenna's Lyme Blog
Yes, I want to subscribe. I understand I will only receive one email each month when there are new posts.
This entry was posted in Lyme Disease News. Bookmark the permalink.

2 Responses to Evaluation of the preventive capacities of a topically applied azithromycin formulation against Lyme borreliosis in a murine model

  1. test1 says:

    I’m no longer certain the place you are getting your info, but good topic. I needs to spend some time learning much more or understanding more. Thank you for wonderful information I was on the lookout for this information for my mission.

Leave a Reply

Your email address will not be published. Required fields are marked *